Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer
International Journal of Molecular Sciences · 18.10.2023 · 24 (20) · 15334
DOI: 10.3390/ijms242015334 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.10.2023. Verfasst von László Madar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Breast Neoplasms, Triple Negative Breast Neoplasms, Ovarian Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund, New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development, and Innovation Fund.
Abstract (Originalsprache)
Hereditary breast cancer is most commonly attributed to germline BRCA1 and BRCA2 gene variants. The vast majority of BRCA1 and BRCA2 mutation carriers are single heterozygotes, and double heterozygosity (DH) is a very rare finding. Here, we describe the case of a BRCA1/BRCA2 double heterozygous female proband diagnosed with breast cancer. Genetic testing for hereditary breast and ovarian cancer revealed two pathogenic variants in the BRCA1 (c.5095C>T, p.(Arg1699Trp)) and in BRCA2 genes (c.658_659delGT, p.(Val220Ilefs*4)) in heterozygous form. None of the variants were founder Jewish mutations; to our knowledge, these rare deleterious variants have not been previously described in DH patients in the literature. The patient had triple-negative unilateral breast cancer at the age of 36 and 44 years. Based on family studies, the BRCA1 variant was maternally inherited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
- Doctoral School of Molecular Cell and Immune Biology, University of Debrecen, 4032 Debrecen, Hungary.
- Department of Oncoradiology, Nyíregyházi Jósa András Tagkórház, Szabolcs-Szatmár-Bereg County Teaching Hospital, 4400 Nyíregyháza, Hungary.
- National Tumorbiology Laboratory Budapest, Department of Molecular Genetics, National Institute of Oncology, 1122 Budapest, Hungary.
- Department of Human Genetics, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
- Division of Clinical Genetics, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
ORCID-Profile: Zsuzsanna Szűcs, Attila Patócs, István Balogh
Förderung
- New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund
- New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development, and Innovation Fund
Zitieren
APA
Madar, L., Majoros, V., Szűcs, Z., Nagy, O., Babicz, T., Butz, H., Patócs, A., Balogh, I., & Koczok, K. (2023). Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer. International Journal of Molecular Sciences, 24(20), 15334. https://doi.org/10.3390/ijms242015334
Vancouver
Madar L, Majoros V, Szűcs Z, Nagy O, Babicz T, Butz H, et al. Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer. International Journal of Molecular Sciences. 2023;24(20):15334. doi:10.3390/ijms242015334
BibTeX
@article{Madar2023,
author = {Madar, László and Majoros, Viktória and Szűcs, Zsuzsanna and Nagy, Orsolya and Babicz, Tamás and Butz, Henriett and Patócs, Attila and Balogh, István and Koczok, Katalin},
title = {Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {20},
pages = {15334},
doi = {10.3390/ijms242015334}
}
EUVIMED